Mannkind (MNKD) Return on Capital Employed Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -2,498.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,498.00 |
| Dec 31, 2025 | -1,269.00 |
| Sep 30, 2025 | 709.00 |
| Jun 30, 2025 | 1,024.00 |
| Mar 31, 2025 | 1,902.00 |
| Dec 31, 2024 | 1,795.00 |
| Sep 30, 2024 | 1,955.00 |
| Jun 30, 2024 | 2,488.00 |
| Mar 31, 2024 | 3,104.00 |
| Dec 31, 2023 | 3,116.00 |
| Sep 30, 2023 | 2,727.00 |
| Jun 30, 2023 | 1,765.00 |
| Mar 31, 2023 | 103.00 |
| Dec 31, 2022 | -788.00 |
| Sep 30, 2022 | -876.00 |
| Jun 30, 2022 | -856.00 |
| Mar 31, 2022 | 958.00 |
| Dec 31, 2021 | 14,815.00 |
| Sep 30, 2021 | -53,922.00 |
| Jun 30, 2021 | 12,742.00 |
| Mar 31, 2021 | 17,073.00 |
| Dec 31, 2020 | -1,370.00 |
| Sep 30, 2020 | 68,473.00 |
| Jun 30, 2020 | 22,391.00 |
| Mar 31, 2020 | 3,520.00 |
| Dec 31, 2019 | 578,544.00 |
| Sep 30, 2019 | -183,353.00 |
| Jun 30, 2019 | -118,298.00 |
| Mar 31, 2019 | -178,940.00 |
| Dec 31, 2018 | -657,408.00 |
| Sep 30, 2018 | 127,670.00 |
| Jun 30, 2018 | 234,825.00 |
| Mar 31, 2018 | -65,052.00 |
| Dec 31, 2017 | -7,071.00 |
| Sep 30, 2017 | 200,882.00 |
| Jun 30, 2017 | -173,344.00 |
| Mar 31, 2017 | 195,459.00 |
| Dec 31, 2016 | 18,321.00 |
| Sep 30, 2016 | -140,906.00 |
| Jun 30, 2016 | 100,851.00 |
| Mar 31, 2016 | -429,484.00 |
| Dec 31, 2015 | -89,029.00 |
| Sep 30, 2015 | 89,051.00 |
| Jun 30, 2015 | -63,129.00 |
| Mar 31, 2015 | 462,937.00 |
| Dec 31, 2014 | 152,822.00 |
| Sep 30, 2014 | -62,719.00 |
| Jun 30, 2014 | -45,974.00 |
| Mar 31, 2014 | -57,130.00 |
| Dec 31, 2013 | 5,423.00 |
| Sep 30, 2013 | -39,273.00 |
| Jun 30, 2013 | 35,172.00 |
| Mar 31, 2013 | 55,425.00 |
| Dec 31, 2012 | -9,540.00 |
| Sep 30, 2012 | -1,497.00 |